| Risk of tuberculosis is higher with anti–tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: the three‐year prospective … F Tubach, D Salmon, P Ravaud, Y Allanore, P Goupille, M Bréban, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2009 | 780 | 2009 |
| Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci Groupe Française d'Etude Génétique des Spondylarthrites (GFEGS), ... Nature genetics 45 (7), 730-738, 2013 | 746 | 2013 |
| Assessment of peripheral enthesitis in the spondylarthropathies by ultrasonography combined with power Doppler: a cross‐sectional study MA D'Agostino, R Said‐Nahal, C Hacquard‐Bouder, JL Brasseur, ... Arthritis & Rheumatism 48 (2), 523-533, 2003 | 692 | 2003 |
| Association between weight or body mass index and hand osteoarthritis: a systematic review E Yusuf, RG Nelissen, A Ioan-Facsinay, V Stojanovic-Susulic, J DeGroot, ... Annals of the rheumatic diseases 69 (4), 761-765, 2010 | 574 | 2010 |
| Ophthalmic findings and frequency of extraocular manifestations in patients with HLA-B27 uveitis: a study of 175 cases D Monnet, M Breban, C Hudry, M Dougados, AP Brézin Ophthalmology 111 (4), 802-809, 2004 | 342 | 2004 |
| Double echo steady state magnetic resonance imaging of knee articular cartilage at 3 Tesla: a pilot study for the Osteoarthritis Initiative F Eckstein, M Hudelmaier, W Wirth, B Kiefer, R Jackson, J Yu, CB Eaton, ... Annals of the rheumatic diseases 65 (4), 433-441, 2006 | 338 | 2006 |
| Faecal microbiota study reveals specific dysbiosis in spondyloarthritis M Breban, J Tap, A Leboime, R Said-Nahal, P Langella, G Chiocchia, ... Annals of the rheumatic diseases 76 (9), 1614-1622, 2017 | 331 | 2017 |
| Quantitative metagenomics reveals unique gut microbiome biomarkers in ankylosing spondylitis C Wen, Z Zheng, T Shao, L Liu, Z Xie, E Le Chatelier, Z He, W Zhong, ... Genome biology 18, 1-13, 2017 | 306 | 2017 |
| Three multicenter, randomized, double‐blind, placebo‐controlled studies evaluating the efficacy and safety of ustekinumab in axial spondyloarthritis A Deodhar, LS Gensler, J Sieper, M Clark, C Calderon, Y Wang, Y Zhou, ... Arthritis & Rheumatology 71 (2), 258-270, 2019 | 293 | 2019 |
| The DESIR cohort: a 10-year follow-up of early inflammatory back pain in France: study design and baseline characteristics of the 708 recruited patients M Dougados, MA d’Agostino, J Benessiano, F Berenbaum, M Breban, ... Joint bone spine 78 (6), 598-603, 2011 | 268 | 2011 |
| Major histocompatibility complex associations of ankylosing spondylitis are complex and involve further epistasis with ERAP1 A Cortes, SL Pulit, PJ Leo, JJ Pointon, PC Robinson, MH Weisman, ... Nature communications 6 (1), 7146, 2015 | 267 | 2015 |
| Susceptibility to inflammatory disease in HLA-B27 transgenic rat lines correlates with the level of B27 expression. JD Taurog, SD Maika, WA Simmons, M Breban, RE Hammer Journal of Immunology (Baltimore, Md.: 1950) 150 (9), 4168-4178, 1993 | 266 | 1993 |
| ImmunoChip study implicates antigen presentation to T cells in narcolepsy J Faraco, L Lin, BR Kornum, EE Kenny, G Trynka, M Einen, TJ Rico, ... PLoS genetics 9 (2), e1003270, 2013 | 258 | 2013 |
| Efficacy of rituximab in systemic manifestations of primary Sjögren's syndrome: results in 78 patients of the AutoImmune and Rituximab registry JE Gottenberg, G Cinquetti, C Larroche, B Combe, E Hachulla, O Meyer, ... Annals of the rheumatic diseases 72 (6), 1026-1031, 2013 | 243 | 2013 |
| T cells, but not thymic exposure to HLA-B27, are required for the inflammatory disease of HLA-B27 transgenic rats. M Breban, JL Fernández-Sueiro, JA Richardson, RR Hadavand, ... Journal of immunology (Baltimore, Md.: 1950) 156 (2), 794-803, 1996 | 223 | 1996 |
| Ankylosing spondylitis A Calin Clinics in rheumatic diseases 11 (1), 41-60, 1985 | 221 | 1985 |
| Non–TNF-targeted biologic vs a second anti-TNF drug to treat rheumatoid arthritis in patients with insufficient response to a first anti-TNF drug: a randomized clinical trial JE Gottenberg, O Brocq, A Perdriger, S Lassoued, JM Berthelot, ... Jama 316 (11), 1172-1180, 2016 | 217 | 2016 |
| Which spinal lesions are associated with new bone formation in patients with ankylosing spondylitis treated with anti-TNF agents? A long-term observational study using MRI and … X Baraliakos, F Heldmann, J Callhoff, J Listing, T Appelboom, J Brandt, ... Annals of the rheumatic diseases 73 (10), 1819-1825, 2014 | 213 | 2014 |
| Efficacy of infliximab in refractory ankylosing spondylitis: results of a six‐month open‐label study M Breban, E Vignon, P Claudepierre, V Devauchelle, D Wendling, ... Rheumatology 41 (11), 1280-1285, 2002 | 197 | 2002 |
| Transfer of the inflammatory disease of HLA-B27 transgenic rats by bone marrow engraftment. M Breban, RE Hammer, JA Richardson, JD Taurog The Journal of experimental medicine 178 (5), 1607-1616, 1993 | 189 | 1993 |
